ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Recurrent FSGS Post-Transplantation: Prevalence and Risk Factors

    R. Aguiar,1 A. Gasparini,2 P. Chowdhury,1 D. Game,1 D. Moutzouris.1

    1Department of Nephrology and Transplantation, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom; 2Department of Health Sciences, University of Leicester, Leicester, United Kingdom.

    Introduction: Primary FSGS can recur in the renal allograft and is associated with poor outcomes. The aim of this study was to assess the prevalence…
  • 2018 American Transplant Congress

    Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients

    S. Sethi, J. Choi, A. Vo, A. Peng, K. Lim, R. Najjar, S. Jordan, E. Huang.

    Cedars Sinai Medical Center, Los Angeles.

    Introduction:Efficacy of belatacept when converted from calcineurin inhibitors (CNI) in high immunologic risk patients has not been established. We examined the impact of HLA-sensitization on…
  • 2018 American Transplant Congress

    Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Randomized Controlled Trial

    S. Patel, S. Kuten, R. Knight, J. Nolte, D. Nguyen, E. Graviss, L. Moore, I. Agboli, C. Pham, A. Gaber.

    Houston Methodist Hospital, Houston, TX.

    Fluoroquinolone (FQ) antibiotics have in vitro activity against BK virus, with several reports indicating they may reduce the risk of BK infection in kidney transplant…
  • 2018 American Transplant Congress

    Kidney Quality Influences Patient and Graft Survival in Liver Transplant Recipients with End Stage Renal Disease

    J. Reyes, M. Eerhart, J. Danobeita, P. Chlebeck, L. Zitur, L. Fernandez.

    Surgery, University of Wisconsin, Madison.

    Background: Recent changes in the allocation policy established by UNOS created a competitive algorithm that facilitates the placement of kidneys in liver transplant recipients that…
  • 2018 American Transplant Congress

    Impact of Infections on Patients with Left Ventricle Assist Devices(LVAD): Allo-Sensitization and Heart Transplantation

    C. Buto-Colletti, P. Kimball, K. Shah, M. Quader.

    Virginia Commonwealth University, Richmond.

    Background: The impact of post-LVAD infections on allosensitization and heart transplantation (HT) is unknown. High levels of panel reactive antibodies (PRA) preclude HT but the…
  • 2018 American Transplant Congress

    Significant Anti-CMV/BKV Effect of a Modern Everolimus-Based Regimen Comparted to a Standard Tacrolimus-MPA Regimen in De Novo Kidney Transplant Recipients: ATHENA 12 Months Data on Infections

    A. Hauser,1 C. Sommerer,1 B. Suwelack,1 D. Dragun,1 O. Witzke,1 C. Hugo,1 N. Kamar,2 P. Merville,2 P. Schenker,1 M. Junge,3 F. Thaiss,1 B. Nashan.1

    1Athena Study Group, Germany; 2Athena Study Group, France; 3Novartis, Pharma, Germany.

    The ATHENA trial was designed to compare everolimus [EVR] in combination with tacrolimus [TAC] or cyclosporine A [CyA] vs. a standard regimen of mycophenolic acid…
  • 2018 American Transplant Congress

    Normothermic Machine Perfusion (NMP) Preservation for Human Liver Transplantation in the Cleveland Clinic

    Q. Liu, D. Pezzati, A. Hassan, B. Soliman, P. Grady, S. Maikhor, G. Iuppa, T. Diago Uso, K. Hashimoto, F. Aucejo, M. Fujiki, B. Eghtesad, J. Cywinski, S. Irefin, J. Fung, K. Abu-Elmagd, C. Miller, C. Quintini.

    Cleveland Clinic, Cleveland, OH.

    NMP is a novel preservation method for liver grafts. We transplanted 15 human livers after NMP to test the safety and feasibility of NMP on…
  • 2018 American Transplant Congress

    Thymoglobulin Induction Decreases Risk of Death in HLA-Sensitized Kidney Recipients

    C. Loheac, O. Aubert, M. Assayag, D. Viglietti, C. Lefaucheur, A. Loupy.

    Paris Translational Research Center for Organ Transplantation, Paris, France.

    Anti-thymocyte globulin (ATG) is currently the preferential induction treatment in kidney recipients at high risk for allograft rejection. However, no study has evaluated the benefits…
  • 2018 American Transplant Congress

    Exercise Rehabilitation's Effect on Employment and School Rates in Kidney Transplant Patients

    A. Kastelz,1,2 C. Di Bella,1 I. Tzvetanov,1 B. Fernhall,2 L. Gallon,3 G. Hachaj,4 E. Benedetti.1

    1Surgery, University of Illinois, Chicago, IL; 2Integrative Physiology Lab, University of Illinois, Chicago, IL; 3Internal Medicine Nephrology, Northwestern Medical Group, Chicago, IL; 4GH FitLab, Chicago, IL.

    Unemployment after kidney transplant is common and creates a heavy reliance on public aid. While the exact reason for low employment rates is unknown, patients…
  • 2018 American Transplant Congress

    Impact of Direct Acting Antiviral Agents (DAAs) for Hepatitis C Virus (HCV)-Induced Liver Diseases on Registration and Outcome on Waiting List (WL) for Liver Transplant (LT)

    C. Antoine,1 C. Jasseron,1 F. Conti,2 S. Dharancy,3 C. Duvoux,4 A. Coilly.5

    1Medical and Scientific Department, Agence de la Biomedecine, Agence de la Biomedecine, La Plaine Saint Denis, Saint Denis, France; 2Department of Hepatology, University Hospital La Pitie, Paris, France; 3Department of Hepatology, University Hospital Huriez, Lille, Nord Pas de Calais, France; 4Department of Hepatology, University Hospital Henri Mondor, Créteil, Val de Marne, France; 5Department of Hepatology, University Hospital Paul Brousse, Villejuif, Val de Marne, France.

    2d-generation DAAs have dramatically improved the management of patients with HCV, including patients with advanced diseases. In France, since 2013, DAA have been largely used,…
  • « Previous Page
  • 1
  • …
  • 141
  • 142
  • 143
  • 144
  • 145
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences